Your browser doesn't support javascript.
loading
Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice
Sousa, Larissa Fonseca da Cunha; Coelho, Fernanda Matos; Rodrigues, David Henrique; Campos, Alline Cristina; Barcelos, Luciola da Silva; Teixeira, Mauro Martins; Rachid, Milene Alvarenga; Teixeira, Antonio Lucio.
Afiliación
  • Sousa, Larissa Fonseca da Cunha; Universidade Federal de Minas Gerais. Laboratorio de Imunofarmacologia. Departamento de Bioqufmica e Imunologia. Belo Horizonte. BR
  • Coelho, Fernanda Matos; Universidade Federal de Minas Gerais. Laboratorio de Imunofarmacologia. Departamento de Bioqufmica e Imunologia. Belo Horizonte. BR
  • Rodrigues, David Henrique; Universidade Federal de Minas Gerais. Laboratorio de Imunofarmacologia. Departamento de Bioqufmica e Imunologia. Belo Horizonte. BR
  • Campos, Alline Cristina; Universidade Federal de Minas Gerais. Laboratorio de Imunofarmacologia. Departamento de Bioqufmica e Imunologia. Belo Horizonte. BR
  • Barcelos, Luciola da Silva; Universidade Federal de Minas Gerais. Laboratorio de Imunofarmacologia. Departamento de Bioqufmica e Imunologia. Belo Horizonte. BR
  • Teixeira, Mauro Martins; Universidade Federal de Minas Gerais. Laboratorio de Imunofarmacologia. Departamento de Bioqufmica e Imunologia. Belo Horizonte. BR
  • Rachid, Milene Alvarenga; Universidade Federal de Minas Gerais. Laboratorio de Imunofarmacologia. Departamento de Bioqufmica e Imunologia. Belo Horizonte. BR
  • Teixeira, Antonio Lucio; Universidade Federal de Minas Gerais. Laboratorio de Imunofarmacologia. Departamento de Bioqufmica e Imunologia. Belo Horizonte. BR
Clinics ; 68(3): 391-394, 2013. ilus, graf
Article en En | LILACS | ID: lil-671432
Biblioteca responsable: BR1.1
ABSTRACT

OBJECTIVE:

Ischemic stroke may result from transient or permanent reductions of regional cerebral blood flow. Polymorphonuclear neutrophils have been described as the earliest inflammatory cells to arrive in ischemic tissue. CXCR1/2 receptors are involved in the recruitment of these cells. However, the contribution of these chemokine receptors during transient brain ischemia in mice remains poorly understood. In this work, we investigated the effects of reparixin, an allosteric antagonist of CXCR1/2 receptors, in a model of middle cerebral artery occlusion and reperfusion in mice.

METHODS:

C57BL/6J male mice treated with reparixin or vehicle were subjected to a middle cerebral artery occlusion procedure 1 h after the treatment. Ninety minutes after ischemia induction, the monofilament that prevented blood flow was removed. Twenty-four hours after the reperfusion procedure, behavioral changes, including motor signs, were analyzed with the SmithKline/Harwell/lmperial College/Royal Hospital/Phenotype Assessment (SHIRPA) battery. The animals were sacrificed, and brain tissue was removed for histological and biochemical analyses. Histological sections were stained with hematoxylin and eosin, neutrophil infiltration was estimated by myeloperoxidase activity and the inflammatory cytokine IL-iβ was measured by ELISA.

RESULTS:

Pre-treatment with reparixin reduced the motor deficits observed in this model of ischemia and reperfusion. Myeloperoxidase activity and IL-iβ were reduced in the reparixin-treated group. Histological analysis revealed that ischemic injury was also attenuated by reparixin pre-treatment.

CONCLUSIONS:

Our results suggest that the blockade of the CXCR1/2 receptors by reparixin promotes neuroprotective effects by reducing the levels of polymorphonuclear infiltration in the brain and the tissue damage associated with middle cerebral artery occlusion and reperfusion.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: LILACS Asunto principal: Sulfonamidas / Lesiones Encefálicas / Isquemia Encefálica / Fármacos Neuroprotectores / Accidente Cerebrovascular Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Clinics Asunto de la revista: MEDICINA Año: 2013 Tipo del documento: Article País de afiliación: Brasil

Texto completo: 1 Bases de datos: LILACS Asunto principal: Sulfonamidas / Lesiones Encefálicas / Isquemia Encefálica / Fármacos Neuroprotectores / Accidente Cerebrovascular Tipo de estudio: Prognostic_studies Límite: Animals Idioma: En Revista: Clinics Asunto de la revista: MEDICINA Año: 2013 Tipo del documento: Article País de afiliación: Brasil